Go Pro
→ The Starlink of Energy (From Monument Traders Alliance) (Ad)tc pixel Free TVTX Stock Alerts

Travere Therapeutics (TVTX) Short Interest Ratio & Short Volume

Travere Therapeutics logo
$61.84 +0.40 (+0.66%)
As of 01:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Travere Therapeutics Short Interest Overview

As of July 31, 2026, Travere Therapeutics (TVTX) had a short interest of 11.68 million shares sold short, representing 12.96% of the public float. This marks a -2.82% decrease in short interest since the prior report. The short interest ratio (days to cover) is 9.4, meaning it would take 9.4 days of the average trading volume of 2.11 million shares to cover all short positions.

Current Short Interest
11,676,586 shares
Previous Short Interest
12,015,392 shares
Change Vs. Previous Month
-2.82%
Dollar Volume Sold Short
$652.60 million
Short Interest Ratio
9.4 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
94,260,000 shares
Short Percent of Float
12.96%
Today's Trading Volume
285,454 shares
Average Trading Volume
2,105,037 shares
Today's Volume Vs. Average
14%
Short Selling Travere Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Travere Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TVTX Short Interest Over Time

TVTX Days to Cover Over Time

TVTX Percentage of Float Shorted Over Time

Travere Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202611,676,586 shares $652.60 million -2.8%13.0%9.41 $55.89
7/15/202612,015,392 shares $681.75 million -5.3%13.5%9.15 $56.74
6/30/202612,687,615 shares $720.78 million -5.6%14.3%4.71 $56.81
6/15/202613,437,418 shares $722.93 million -4.9%15.1%6.39 $53.80
5/29/202614,122,154 shares $666.28 million +0.8%15.9%8.16 $47.18
5/15/202614,008,379 shares $596.62 million -1.5%15.8%4.48 $42.59
4/30/202614,216,705 shares $598.81 million +11.7%16.0%7.2 $42.12
4/15/202612,725,544 shares $521.11 million -5.4%14.3%3.73 $40.95
3/31/202613,446,405 shares $399.39 million +0.5%15.1%11.01 $29.70
3/13/202613,383,909 shares $372.07 million -5.6%15.1%10.64 $27.80
2/27/202614,180,739 shares $422.44 million -6.8%16.0%9.69 $29.79
2/13/202615,217,326 shares $423.35 million +5.0%17.1%10.77 $27.82
1/30/202614,491,659 shares $450.55 million -5.7%16.3%8.67 $31.09
1/15/202615,365,503 shares $436.38 million +7.4%17.3%3.45 $28.40
12/31/202514,312,827 shares $546.89 million +17.4%16.1%7.31 $38.21
12/15/202512,196,281 shares $423.94 million +11.2%13.7%8.06 $34.76
11/28/202510,969,722 shares $390.25 million +5.9%12.3%8.35 $35.58
11/14/202510,355,808 shares $357.28 million -4.8%12.1%4.81 $34.50
10/31/202510,879,506 shares $382.52 million -8.1%12.7%4.98 $35.16
10/15/202511,840,000 shares $317.90 million +5.3%13.8%5.8 $26.85
9/30/202511,240,000 shares $268.64 million -8.8%N/A5.7 $23.90
9/15/202512,320,000 shares $283.48 million +2.0%N/A6.4 $23.01
8/31/202512,080,000 shares $211.40 million -0.3%14.1%6.7 $17.50
8/15/202512,110,000 shares $227.91 million +14.0%N/A8.1 $18.82
7/31/202510,620,000 shares $164.08 million -17.4%12.4%6.8 $15.45
7/15/202512,860,000 shares $210.65 million +857,233.3%N/A7.9 $16.38
6/30/20251,500 shares $22.20 thousand -100.0%0.0%0 $14.80
6/15/202510,330,000 shares $149.79 million -17.4%12.1%5.9 $14.50
5/31/202512,500,000 shares $187.25 million +19.9%16.6%7.1 $14.98
5/15/202510,430,000 shares $220.59 million -2.0%13.9%5.8 $21.15
4/30/202510,640,000 shares $221.42 million -3.7%N/A5.7 $20.81
4/15/202511,050,000 shares $164.76 million -4.4%14.7%6.2 $14.91
3/31/202511,560,000 shares $207.16 million +3.3%15.4%6.6 $17.92
3/15/202511,190,000 shares $220.78 million +2.2%14.9%7 $19.73
2/28/202510,950,000 shares $234.33 million -3.1%14.6%7.2 $21.40
2/15/202511,300,000 shares $258.88 million +18.2%15.0%7.7 $22.91
1/31/20259,560,000 shares $195.60 million -0.2%N/A6.8 $20.46
1/15/20259,580,000 shares $173.11 million +9.9%N/A7.4 $18.07
12/31/20248,720,000 shares $151.90 million +17.7%N/A5.9 $17.42
12/15/20247,410,000 shares $128.34 million -2.1%N/A4.5 $17.32
Trump’s New Currency Reset (Ad)

Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel

Watch the documentary briefing and find out which side you land on
11/30/20247,570,000 shares $142.39 million +8.6%N/A4.3 $18.81
11/15/20246,970,000 shares $123.51 million -12.8%N/A3.6 $17.72
10/31/20247,990,000 shares $139.83 million -1.5%N/A4.4 $17.50
10/15/20248,110,000 shares $143.47 million +16.5%N/A4.7 $17.69
9/30/20246,960,000 shares $97.37 million -19.6%N/A4.2 $13.99
9/15/20248,660,000 shares $116.74 million -6.4%N/A6.2 $13.48
8/31/20249,250,000 shares $87.60 million -0.5%N/A7.2 $9.47
8/15/20249,300,000 shares $81.65 million -7.8%N/A8.5 $8.78
7/31/202410,090,000 shares $96.26 million -0.1%N/A8.8 $9.54
7/15/202410,100,000 shares $99.08 million -2.1%N/A8.2 $9.81
6/30/202410,320,000 shares $84.83 million -23.1%N/A8.2 $8.22
6/15/202413,414,700 shares $96.18 million -0.4%N/A11 $7.17
5/31/202413,470,000 shares $99.95 million +0.2%N/A11.3 $7.42
5/15/202413,440,000 shares $91.39 million +4.9%N/A11 $6.80
4/30/202412,810,000 shares $70.84 million +8.6%N/A10.3 $5.53
4/15/202411,800,000 shares $74.58 million +11.3%N/A9.9 $6.32
3/31/202410,600,000 shares $81.73 million +5.3%N/A8.8 $7.71
3/15/202410,070,000 shares $75.42 million -1.9%N/A8.2 $7.49
2/29/202410,260,000 shares $77.57 million +5.1%N/A7.5 $7.56
2/15/20249,760,000 shares $85.30 million -1.7%N/A6.7 $8.74
1/31/20249,930,000 shares $88.67 million +2.3%N/A6.3 $8.93
1/15/20249,710,000 shares $92.54 million -2.1%N/A5.8 $9.53
12/31/20239,920,000 shares $89.18 million +2.9%N/A5.9 $8.99
12/15/20239,640,000 shares $83.48 million -3.1%N/A5.8 $8.66
11/30/20239,950,000 shares $62.49 million -6.7%N/A5 $6.28
11/15/202310,660,000 shares $65.77 million +21.0%N/A5.9 $6.17
10/31/20238,810,000 shares $57.09 million +0.5%N/A5.2 $6.48
10/15/20238,770,000 shares $62.27 million +4.2%N/A5.6 $7.10
9/30/20238,420,000 shares $75.27 million -6.9%N/A5.8 $8.94
9/15/20239,040,000 shares $123.76 million +5.7%N/A6.7 $13.69
8/31/20238,550,000 shares $122.09 million +5.6%N/A8.3 $14.28
8/15/20238,100,000 shares $123.12 million +0.4%N/A7.6 $15.20
7/31/20238,070,000 shares $138.72 million -2.7%N/A7.3 $17.19
7/15/20238,290,000 shares $126.92 million -2.5%N/A6.5 $15.31
6/30/20238,500,000 shares $130.56 million +11.0%N/A6.3 $15.36
6/15/20237,660,000 shares $131.75 million +4.9%N/A5.4 $17.20
5/31/20237,300,000 shares $130.60 million -3.2%N/A5.4 $17.89
5/15/20237,540,000 shares $123.20 million -4.1%N/A4.7 $16.34
4/30/20237,860,000 shares $169.54 million -3.7%N/A4.7 $21.57
4/15/20238,160,000 shares $165.81 million -4.5%N/A5.6 $20.32
3/31/20238,540,000 shares $192.06 million +14.8%N/A5.7 $22.49
3/15/20237,440,000 shares $158.25 million -1.6%N/A5.4 $21.27
2/28/20237,560,000 shares $167.53 million +9.9%N/A5.7 $22.16
2/15/20236,880,000 shares $138.43 million -7.7%N/A5.8 $20.12
1/31/20237,450,000 shares $166.88 million -0.9%N/A8.8 $22.40
1/15/20237,520,000 shares $152.81 million -10.3%N/A9.1 $20.32
12/30/20228,380,000 shares $176.23 million +3.1%N/A10 $21.03
12/15/20228,130,000 shares $150.41 million -1.2%N/A9.7 $18.50
11/30/20228,230,000 shares $165.67 million +5.9%N/A10.6 $20.13
11/15/20227,770,000 shares $167.13 million -1.2%N/A10.4 $21.51
Trump’s New Currency Reset (Ad)

Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel

Watch the documentary briefing and find out which side you land on
10/31/20227,860,000 shares $170.40 million +23.0%13.0%10.9 $21.68
10/15/20226,390,000 shares $132.15 million -6.2%10.6%8.4 $20.68
9/30/20226,810,000 shares $167.80 million +3.0%11.3%10.3 $24.64
9/15/20226,610,000 shares $179.79 million -0.5%11.0%9.9 $27.20
8/31/20226,640,000 shares $177.69 million -10.2%11.1%9 $26.76
8/15/20227,390,000 shares $211.28 million +7.9%12.3%9.7 $28.59
7/31/20226,850,000 shares $161.25 million +2.4%11.5%7.9 $23.54
7/15/20226,690,000 shares $163.97 million -5.0%11.2%8.4 $24.51
6/30/20227,040,000 shares $170.58 million +6.2%11.8%8.6 $24.23
6/15/20226,630,000 shares $160.18 million -10.4%11.1%8 $24.16
5/31/20227,400,000 shares $172.49 million -12.6%12.4%8.9 $23.31
5/15/20228,470,000 shares $187.86 million +3.7%14.2%9.7 $22.18
4/30/20228,170,000 shares $205.31 million +14.1%13.8%10.5 $25.13
4/15/20227,160,000 shares $212.22 million +0.7%12.1%9.3 $29.64
3/31/20227,110,000 shares $183.22 million -6.5%12.0%9.8 $25.77
3/15/20227,600,000 shares $181.72 million +29.3%12.8%11.5 $23.91
2/28/20225,880,000 shares $160.29 million -1.7%10.0%9.1 $27.26
2/15/20225,980,000 shares $171.39 million +11.4%10.5%11 $28.66
1/31/20225,370,000 shares $147.68 million +8.5%9.3%10.6 $27.50
1/15/20224,950,000 shares $136.32 million -15.5%8.5%9.3 $27.54
12/31/20215,860,000 shares $181.89 million -6.4%N/A0 $31.04
12/15/20216,260,000 shares $182.48 million +0.6%10.8%11.6 $29.15
11/30/20216,220,000 shares $177.58 million +3.0%10.7%10.5 $28.55
11/15/20216,040,000 shares $177.39 million -1.2%10.4%9.7 $29.37
10/29/20216,110,000 shares $176.03 million +0.5%10.1%5 $28.81
10/15/20216,080,000 shares $148.96 million -6.9%10.2%5.1 $24.50
9/30/20216,530,000 shares $158.35 million -5.6%10.9%5.4 $24.25
9/15/20216,920,000 shares $162.83 million -3.1%11.5%5.4 $23.53
8/31/20217,140,000 shares $155.87 million +6.7%11.9%5.5 $21.83

TVTX Short Interest - Frequently Asked Questions

Short interest is the volume of Travere Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 11,676,586 shares of TVTX short. 12.96% of Travere Therapeutics' shares are currently sold short. Learn More on Travere Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TVTX shares currently have a short interest ratio of 9.4. Learn More on Travere Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.96% of Travere Therapeutics' floating shares are currently sold short.

Travere Therapeutics saw a decrease in short interest in July. As of July 31st, there was short interest totaling 11,676,586 shares, a decrease of 2.8% from the previous total of 12,015,392 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

12.96% of Travere Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Travere Therapeutics: United Therapeutics Corporation (5.92%), Genmab A/S Sponsored ADR (1.20%), BridgeBio Pharma, Inc. (13.92%), Ascendis Pharma A/S (9.10%), Exelixis, Inc. (11.74%), BioMarin Pharmaceutical Inc. (6.50%), Arrowhead Pharmaceuticals, Inc. (7.11%), Madrigal Pharmaceuticals, Inc. (10.33%), Halozyme Therapeutics, Inc. (12.67%), Summit Therapeutics PLC (27.54%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling TVTX is an investing strategy that aims to generate trading profit from Travere Therapeutics as its price is falling. TVTX shares are trading up $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Travere Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TVTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TVTX, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like TVTX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:TVTX is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Buffett's Final Warning: "The Dollar Is Going to Hell"
The US just hit $39 trillion in debt. Interest alone is now over $1 trillion a year, more than the entire defe...
Decentralized Masters | Sponsoredtc pixel
After KDA, PRE, and OCEAN—this is the one
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel